# Tema Heart & Health ETF (HRTS): ETF Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/hrts for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Tema · Asset class: Equity - Strategy: Thematic · Inception: 2023-11-20 The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management. ## Key Facts | Metric | Value | |---|---| | Price | $37.45 | | Expense Ratio | 0.99% | | Assets Under Management | $55.9M | | NAV | $37.79 | | Holdings Count | 46 | | Distribution Yield (TTM) | 1.26% | | Annual Distribution (TTM) | $0.47 /share | | Distribution Frequency | Annual | | 52-Week Range | $32.00 – $38.87 | | Beta | 0.66 | ## Latest Distribution - Amount: $0.4729 /share - Ex-date: 2025-12-10 - Pay date: 2025-12-11 ## Frequently Asked Questions ### What does HRTS invest in? The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management. ### What is the expense ratio of HRTS? Tema Heart & Health ETF (HRTS) charges an expense ratio of 0.99%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is HRTS? Tema Heart & Health ETF (HRTS) manages $55.9M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is HRTS actively managed or an index fund? HRTS's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was HRTS launched? Tema Heart & Health ETF (HRTS) launched in November 2023 and is managed by Tema. ### How has HRTS performed? HRTS's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does HRTS pay a dividend? Tema Heart & Health ETF (HRTS) currently distributes little or no income. Trailing-twelve-month yield is 1.26%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does HRTS pay dividends? Tema Heart & Health ETF pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is HRTS's dividend yield? HRTS's trailing-twelve-month yield is 1.26%, calculated from the sum of dividends over the past year divided by the current price. ### When is HRTS's next ex-dividend date? The most recently announced ex-dividend date for HRTS was 2025-12-10. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will HRTS's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.99% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does HRTS charge its expense ratio? The expense ratio is deducted in tiny daily slices from HRTS's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does HRTS cost more than a fund like VOO? HRTS's strategy (current expense ratio 0.99%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where HRTS sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to HRTS? The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as HRTS (0.99%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/hrts - Distribution history: https://www.dividenddata.com/funds/hrts/dividend - Holdings & diversification: https://www.dividenddata.com/funds/hrts/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/hrts/expenses - Peer comparison: https://www.dividenddata.com/funds/hrts/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.